ETF PROAI

FDHTvsXPH

Fidelity Digital Health ETF against SPDR S&P Pharmaceuticals ETF — the fee, the flows, the book, and a year head-to-head.

One year, growth of $100
FDHT 92XPH 104Oct 25Nov 25GROWTH OF $100
Head to head
FDHTXPH
Expense ratio0.39%0.35%
Assets$8829.23T$524M
Net flow, 1 month—−$43M
Net flow, 1 year—+$271M
Return, YTD—+13.6%
Return, 1 year-7.9%+31.8%
Avg daily volume—188K
Holdings5741
ListedOct 7, 2021Jun 19, 2006
Options marketNoYes

MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS

THE DESK BRIEF

Flows, fee cuts, and closure risk on the funds you watch — every trading morning.